Search research articles
Contact Us
Filters
Showing results (61-70 of 350) with videos related to
Page
of 35
Sort By:
European Journal of Medical Genetics
|
November 10, 2022
Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions
Johannes Gojo, Mimi Kjaersgaard, Barbara V Zezschwitz, et al.
Nature Communications
|
February 20, 2025
Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
Salvatore Benfatto, Martin Sill, David T W Jones, et al.
International Journal of Cancer
|
September 14, 2011
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size
David Capper, Matthias Simon, Claus-Dieter Langhans, et al.
Neuro-Oncology
|
May 28, 2010
Defective p53 antiangiogenic signaling in glioblastoma
Benjamin Berger, David Capper, Dieter Lemke, et al.
Human Pathology
|
October 24, 2012
Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR
Hans Bösmüller, Anna Fischer, Deborah L Pham, et al.
Histopathology
|
June 29, 2011
Immunohistochemical analysis of 1844 human epithelial and haematopoietic tumours and sarcomas for IDH1R132H mutation
Felix Sahm, David Capper, Jochen Meyer, et al.
Pathology, Research and Practice
|
December 1, 2019
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
Anne K Braczynski, David Capper, David T W Jones, et al.
Acta Neuropathologica
|
August 2, 2013
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
Benedikt Wiestler, David Capper, Tim Holland-Letz, et al.
BMC Cancer
|
February 12, 2016
Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
Christine Jungk, Despina Chatziaslanidou, Rezvan Ahmadi, et al.
Journal of Neuropathology and Experimental Neurology
|
February 28, 2016
Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis
Dieter Henrik Heiland, Ori Staszewski, Martin Hirsch, et al.
Page
of 35
Search research articles
Search
Showing results (61-70 of 350) with videos related to
Sort By:
Page
of 35
European Journal of Medical Genetics
|
November 10, 2022
Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions
Johannes Gojo, Mimi Kjaersgaard, Barbara V Zezschwitz, et al.
Nature Communications
|
February 20, 2025
Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
Salvatore Benfatto, Martin Sill, David T W Jones, et al.
International Journal of Cancer
|
September 14, 2011
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size
David Capper, Matthias Simon, Claus-Dieter Langhans, et al.
Neuro-Oncology
|
May 28, 2010
Defective p53 antiangiogenic signaling in glioblastoma
Benjamin Berger, David Capper, Dieter Lemke, et al.
Human Pathology
|
October 24, 2012
Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR
Hans Bösmüller, Anna Fischer, Deborah L Pham, et al.
Histopathology
|
June 29, 2011
Immunohistochemical analysis of 1844 human epithelial and haematopoietic tumours and sarcomas for IDH1R132H mutation
Felix Sahm, David Capper, Jochen Meyer, et al.
Pathology, Research and Practice
|
December 1, 2019
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma
Anne K Braczynski, David Capper, David T W Jones, et al.
Acta Neuropathologica
|
August 2, 2013
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
Benedikt Wiestler, David Capper, Tim Holland-Letz, et al.
BMC Cancer
|
February 12, 2016
Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
Christine Jungk, Despina Chatziaslanidou, Rezvan Ahmadi, et al.
Journal of Neuropathology and Experimental Neurology
|
February 28, 2016
Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis
Dieter Henrik Heiland, Ori Staszewski, Martin Hirsch, et al.
Page
of 35